Get started

Indictors

Gold (XAU/USD) 1H Analysis – Potential Breakout Play🟡 Gold (XAU/USD) 1H Analysis – Potential Breakout Play 📈 🔎 Key Levels and Zones Resistance Zone: Around $3,410 – $3,430. Midpoint/Key Resistance-Turned-Support: Around $3,360 – $3,370. Support Zone: Around $3,270 – $3,290. 🔀 Chart Structure & Momentum The price is in a short-term bullish recovery after finding strong support at the $3,270 – $3,290 level. The breakout above the midpoint around $3,360 is a significant bullish trigger, suggesting that bulls are taking charge. 📊 Scenario Analysis Bullish Scenario (Primary Bias) 🟢: If the price holds above the midpoint ($3,360), we expect a push towards the resistance zone ($3,410 – $3,430). This aligns with the “resistance-flip-support” concept, where the previous resistance becomes a new support base. Bearish Scenario (Alternate Bias) 🔴: If the price fails to hold above $3,360, a re-test of the support zone ($3,270 – $3,290) is likely. From there, bulls will likely try to defend the area and launch another attempt upwards. 📌 Conclusion The path of least resistance currently favors the bulls while the $3,360 level holds. Watch for consolidation near $3,360 – $3,370 as a healthy retest before potential continuation to the upside target zone ($3,410 – $3,430). 📅 Near-Term Bias Remain cautiously bullish while above $3,360. A confirmed breakout above $3,410 opens room for further bullish momentum, while a breakdown below $3,360 can re-test the key support at $3,270.
OANDA:XAUUSDLong
by VikingFx-Community
NASDAQ Bullish Breakout Above Channel;📈 Technical Analysis Overview 1. Breakout from Downtrend Channel The price has clearly broken out of a descending channel, confirmed by a clean breakout above the upper trendline. This is a bullish signal, indicating the end of the prior downtrend and the start of a possible uptrend or reversal. 2. Moving Averages (EMA 50 & EMA 200) EMA 50 (Red): 18,965 EMA 200 (Blue): 19,409 Price is currently trading above both EMAs, which is another strong bullish indicator. A bullish crossover (where EMA 50 crosses above EMA 200) is likely imminent if upward momentum continues—this would form a Golden Cross, further confirming bullish sentiment. 3. Structure and Market Behavior After the breakout, price retested the breakout zone and showed a bounce, forming a higher low, which is characteristic of a bullish structure. The chart includes projected price action with higher highs and higher lows—suggesting a bullish continuation pattern. 4. Volume & Momentum (Not shown but implied) Breakouts are typically validated by volume. Although volume is not shown, the sharp upward movement and breakout above resistance suggest strong buying pressure. 🔍 Key Levels to Watch Resistance: 20,000 psychological level; above that, 20,500–21,000 may act as resistance. Support: 19,400 (near EMA 200), and 18,965 (EMA 50); a break below may invalidate the bullish setup. 📊 Conclusion The chart shows a clear breakout from a descending channel, supported by the price moving above both key EMAs. The structure favors bullish continuation, especially if price holds above the 19,400–19,500 support zone. Upside targets lie around 20,500 to 21,000.
IG:NASDAQLong
by MrStellanSight
8
THIS IS BHARTI AIRTEL IDEA FOR TRADINGAs we can see stock is trading above 50ema and making hammer candles with good volume. from ATH and rsi divergence stock correct almost 5% And Doji candle on 8th Dec after a downtrend ends and the next candle formed is a hammer candlestick. which is indicating a bullish reversal, Singh. Bharti Airtel Ties Up with Meta, STC to Bring World's Longest Subsea Cable to India. (07-12-2022) The chart mentions a good support level and entry point, so plan accordingly. if you are a value buyer wait for more cuts till S1 and S2. otherwise, you can enter with strict SL which is mentioned on the chart. GOOD STOCK FOR THE LONG RUN ALL THE BEST! indicators HV=14 RSI=52 educational purpose only!
NSE:BHARTIARTLLong
by SHEHBAZ_KHAN
CLSD - Triple Bottom. Huge Analyst Prediction Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA. Average Recommendation: OVERWEIGHT Average Target Price: 5.50 SHORT INTEREST 2.26M 07/15/19 P/E Current -0.48 P/E Ratio (with extraordinary items) -0.72
NASDAQ:CLSDLong
by DEXWireNews